Trial Profile
Safety and Efficacy of Pegylated Liposomal Doxorubicin-based Adjuvant Chemotherapy in Patients with Stage I-III Triple-negative Breast Cancer.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 28 Dec 2015
Price :
$35
*
At a glance
- Drugs Doxorubicin liposomal (Primary)
- Indications Advanced breast cancer; Breast cancer; Early breast cancer; Triple negative breast cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Dec 2015 New trial record